Mitigation of hyperglycemia-induced leydig cell dysfunction by gut derived indol 3- propionic acid: Targeting...

Indole-3-propionic acid (IPA), a gut-derived compound, has demonstrated promising antidiabetic, anti-inflammatory, and antioxidant properties. However, its potential role in mitigating male reproductive dysfunction, particularly in the context of hyperglycemia, remains poorly understood. This study aims to investigate the effect of IPA on the Leydig cell dysfunction under hyperglycemic (HG) condition. TM3 mouse Leydig cells were cultured in DMEM/F12 medium containing low (5 mM) and high (30 mM) glucose concentrations in the presence of 10 and 20 µM of IPA for 24 h. Cell viability was assessed by MTT method. The expression of steroidogenesis associated genes 3β-hydroxysteroid dehydrogenase; (Hsd3b1), follicle-stimulating hormone receptor (Fshr), cytochrome P450 side-chain cleavage enzyme(P450scc), and steroidogenic acute regulatory protein (Star)) was evaluated by qRT-PCR analysis.The protein levels of endoplasmic reticulum stress (ERS) related proteins (ATF6, IRE1, GRP78, and CHOP) were determined by Western blot analysis. Testosterone levels were measured by ELISA method. Cell apoptosis was determined using Anexinv/PI flow cytometery analysis. Hyperglycemia decreased cell viability, testosterone production, and the expression of Hsd3b1, Fshr, P450scc, and Star in TM3 cells. Under hyperglycemic conditions, TM3 cells exhibited increased apoptosis and elevated expression of ATF6, PERK, GRP78, and CHOP proteins. IPA, particularly at a dose of 20 µM, increased cell viability and enhanced the expression of steroidogenesis-related genes under HG conditions. Additionally, IPA at doses of 10 and 20 µM attenuated apoptosis and reduced the expression of ERS proteins under HG. The potential therapeutic role of IPA in alleviating the complications caused by hyperglycemia in Leydig cells makes it a promising candidate in the treatment of male reproductive dysfunction associated with diabetes.